These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12376155)

  • 1. Locomotor stimulant effects of nornicotine: role of dopamine.
    Green TA; Brown RW; Phillips SB; Dwoskin LP; Bardo MT
    Pharmacol Biochem Behav; 2002 Dec; 74(1):87-94. PubMed ID: 12376155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices.
    Green TA; Crooks PA; Bardo MT; Dwoskin LP
    Biochem Pharmacol; 2001 Dec; 62(12):1597-603. PubMed ID: 11755112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats.
    Boye SM; Grant RJ; Clarke PB
    Neuropharmacology; 2001 May; 40(6):792-805. PubMed ID: 11369033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression.
    Bevins RA; Besheer J; Pickett KS
    Pharmacol Biochem Behav; 2001 Jan; 68(1):135-45. PubMed ID: 11274718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
    Dalia A; Uretsky NJ; Wallace LJ
    Brain Res; 1998 Mar; 788(1-2):111-7. PubMed ID: 9554973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats.
    Louis M; Clarke PB
    Neuropharmacology; 1998 Dec; 37(12):1503-13. PubMed ID: 9886673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
    Clarke PB; Fu DS; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1988 Aug; 246(2):701-8. PubMed ID: 3136244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists.
    Rowlett JK; Mattingly BA; Bardo MT
    Synapse; 1995 Jul; 20(3):209-16. PubMed ID: 7570352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats.
    Benwell ME; Balfour DJ
    Br J Pharmacol; 1998 Nov; 125(6):1115-9. PubMed ID: 9863636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine.
    Cadoni C; Di Chiara G
    Eur J Pharmacol; 2000 Jan; 387(3):R23-5. PubMed ID: 10650185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of catecholamines in desmopressin induced locomotor stimulation.
    Di Michele S; Ericson M; Sillén U; Engel JA; Söderpalm B
    J Neural Transm (Vienna); 1998; 105(10-12):1103-15. PubMed ID: 9928881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.
    Rezvani AH; Eddins D; Slade S; Hampton DS; Christopher NC; Petro A; Horton K; Johnson M; Levin ED
    Neuroscience; 2008 Jun; 154(3):885-97. PubMed ID: 18511204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.
    Jeziorski M; White FJ
    Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization.
    White FJ; Joshi A; Koeltzow TE; Hu XT
    Neuropsychopharmacology; 1998 Jan; 18(1):26-40. PubMed ID: 9408916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization.
    De Vries TJ; Cools AR; Shippenberg TS
    Neuroreport; 1998 Jun; 9(8):1763-8. PubMed ID: 9665597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens.
    Breysse N; Risterucci C; Amalric M
    Pharmacol Biochem Behav; 2002 Sep; 73(2):347-57. PubMed ID: 12117589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats.
    Kita T; Okamoto M; Nakashima T
    Life Sci; 1992; 50(8):583-90. PubMed ID: 1736029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
    Kiyatkin EA; Brown PL
    Eur J Neurosci; 2005 Aug; 22(4):930-8. PubMed ID: 16115216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine enhancement of nicotine self-administration.
    Villégier AS; Lotfipour S; McQuown SC; Belluzzi JD; Leslie FM
    Neuropharmacology; 2007 May; 52(6):1415-25. PubMed ID: 17412372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.